The Carlyle Group Inc. 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 6:00 pm Purchase |
2024-02-08 | 13D | Jasper Therapeutics, Inc. JSPR |
Carlyle Group Inc. CG |
1,066,189 7.100% |
190,000 (+21.68%) |
Filing |
| 2023-01-31 4:15 pm Purchase |
2023-01-27 | 13D | Jasper Therapeutics, Inc. JSPR |
Carlyle Group Inc. CG |
876,189 8.000% |
313,333 (+55.67%) |
Filing |
| 2022-08-11 4:47 pm Purchase |
2022-08-01 | 13D | Jasper Therapeutics, Inc. JSPR |
Carlyle Group Inc. CG |
562,856 15.400% |
562,856 (New Position) |
Filing |